March 12th 2024, 10:08pm
Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit
An expert explained that patients with breast cancer who undergo genetic testing may help their family members, regardless of whether patients have children.
February 5th 2024, 4:00pm
ASCO Gastrointestinal Cancers Symposium
There are a few conversations patients should have with their care teams after being diagnosed with bladder cancer — especially as new treatments become more available.
February 2nd 2024, 10:00pm
ASCO Gastrointestinal Cancers Symposium
Slower infusion rates of antiemetic drugs may help manage nausea and vomiting in patients with gastric or gastroesophageal junction cancers.
January 31st 2024, 10:00pm
Welireg outperformed Afinitor in time to disease progression and patient-reported quality of life in the treatment of metastatic clear cell renal cell carcinoma.
January 30th 2024, 8:00pm
Patients with high-risk prostate cancer who had a higher dose of radiation plus long-term androgen deprivation therapy tended to live longer than those who had a lower dose.
January 30th 2024, 2:00pm
Real-world data demonstrated that knowing a patient’s stage and subtype of renal cell carcinoma, a type of kidney cancer, may provide cancer teams with the information needed to determine potential prognosis and recurrence risk.
January 29th 2024, 11:00pm
Subcutaneous Opdivo led to similar outcomes to intravenous administration of the drug and may be easier to access down the road, an expert said.
January 29th 2024, 10:00pm
Patients with clear cell renal cell carcinoma had improved overall survival when treated with adjuvant Keytruda compared to placebo.
January 29th 2024, 5:00pm
Opdivo failed to improve disease-free survival in patients with localized renal cell carcinoma at high risk of relapse, according to findings from CheckMate 914.
January 29th 2024, 4:00pm
Urinary minimal residual disease-negative status was related to preventing the return of cancer when certain patients with bladder cancer received Adstiladrin.